This section defines biosafety concepts including biohazardous materials, virulence, route of entry, viability, infectious dose, concentration, immune status, and biosafety containment levels (BSL1-4 & ABSL1-4) and infectious agent Risk Groups (RG1-4).
The experimental risk assessment involves identifying, evaluating and determining the proper controls and containment of biological hazards.
This section covers the MU process to acquire, purchase, gift/donate and exemption of biohazardous material. The process begins with becomming a Permitted Individual.
Note: If you are submitting a renewal application and would like a pdf version of your previously approved IBC protocol, please email email@example.com and it will get emailed to you.